Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
3.040
0.00 (0.00%)
Aug 14, 2026, 9:42 AM EDT - Market open
Apyx Medical Revenue
Apyx Medical had revenue of $13.88M in the quarter ending June 30, 2026, with 22.08% growth. This brings the company's revenue in the last twelve months to $58.42M, up 25.59% year-over-year. In the year 2025, Apyx Medical had annual revenue of $52.84M with 9.86% growth.
Revenue (ttm)
$58.42M
Revenue Growth
+25.59%
P/S Ratio
2.19
Revenue / Employee
$284,951
Employees
205
Market Cap
128.06M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 52.84M | 4.74M | 9.86% |
| Dec 31, 2024 | 48.10M | -4.25M | -8.11% |
| Dec 31, 2023 | 52.35M | 7.84M | 17.61% |
| Dec 31, 2022 | 44.51M | -4.01M | -8.26% |
| Dec 31, 2021 | 48.52M | 20.81M | 75.08% |
| Dec 31, 2020 | 27.71M | -524.00K | -1.86% |
| Dec 31, 2019 | 28.24M | 11.63M | 70.04% |
| Dec 31, 2018 | 16.61M | 6.37M | 62.25% |
| Dec 31, 2017 | 10.23M | 1.42M | 16.04% |
| Dec 31, 2016 | 8.82M | -20.70M | -70.13% |
| Dec 31, 2015 | 29.52M | 1.84M | 6.64% |
| Dec 31, 2014 | 27.68M | 4.02M | 16.99% |
| Dec 31, 2013 | 23.66M | -4.01M | -14.50% |
| Dec 31, 2012 | 27.67M | 2.26M | 8.89% |
| Dec 31, 2011 | 25.41M | 1.18M | 4.87% |
| Dec 31, 2010 | 24.23M | -2.72M | -10.10% |
| Dec 31, 2009 | 26.95M | -1.14M | -4.07% |
| Dec 31, 2008 | 28.10M | -682.16K | -2.37% |
| Dec 31, 2007 | 28.78M | 2.10M | 7.88% |
| Dec 31, 2006 | 26.68M | 6.47M | 31.99% |
| Dec 31, 2005 | 20.21M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Inogen | 354.30M |
| Quanterix | 153.41M |
| Outset Medical | 117.80M |
| Owlet | 114.41M |
| Pulmonx | 87.44M |
| electroCore | 36.97M |
| MaxCyte | 32.29M |
| Hyperfine | 16.54M |
APYX News
- 2 days ago - Apyx Medical Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts
- 7 days ago - Apyx Medical reports Q2 EPS (7c), consensus (8c) - TheFly
- 7 days ago - Apyx Medical backs FY26 revenue view $59M-$60M, consensus $59.55M - TheFly
- 7 days ago - Apyx Medical Earnings Call Transcript: Q2 2026 - Transcripts
- 7 days ago - Apyx Medical Earnings release: Q2 2026 - Filings
- 7 days ago - Apyx Medical Quarterly report: Q2 2026 - Filings
- 7 days ago - Apyx Medical Corporation Reports Second Quarter 2026 Financial Results - GlobeNewsWire
- 17 days ago - Apyx Medical Corporation to Participate in the Canaccord Genuity 46th Annual Growth Conference - GlobeNewsWire